Detalhe da pesquisa
1.
Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO).
BMC Cancer
; 19(1): 766, 2019 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31382926